Written in English
This Symposium was the fourth in a series which began in Milan, Italy, in 1960. Each meeting has introduced or developed some new concepts in the areas of lipid metabolism and drugs. The meetings have served as a springboard for new ideas which have, between meetings, become accepted and exploited. This meeting has been no exception. Principal among the many new concepts discussed were lipoprotein synthesis and metabolism, apoprotein structure and function, whole body metabolism of cholesterol, and aspects of myocardial and aortic metabolism. The Symposium also included a summary of current thought on management of hyperlipemias and atherosclerosis. Data on more than 30 drugs were introduced and discussed. We have every expectation that the next Symposium will include material which is now only in the formative stage. The Organizing Committee would like to acknowledge the invaluable assistance of Miss Mary Constant, Mr. Ralph H. Hollerorth, Mrs. Carolyn P. Hyatt and Miss Jane T. Kolimaga, whose efforts contributed significantly (p <.001) to the success of this Symposium.
|Statement||edited by William L. Holmes, Rodolfo Paoletti, David Kritchevsky|
|Series||Advances in Experimental Medicine and Biology -- 26, Advances in experimental medicine and biology -- 26.|
|Contributions||Holmes, William L., editor, Paoletti, Rodolfo, editor, Kritchevsky, David, editor|
|The Physical Object|
|Pagination||1 online resource (XIII, 359 pages 49 illustrations).|
|Number of Pages||359|
|ISBN 10||1468475479, 1468475495|
|ISBN 10||9781468475470, 9781468475494|
Proceedings of a meeting held in Philadelphia, September twenty-two papers on recent developments in clinically significant aspects of lipid biochemistry; drugs affecting cholesterol, fatty acids, triglycerides, lipoproteins, and bile acids; and prospects for prevention of atheromatous heart disease. Book Notes | 1 June Pharmacological Control of Lipid Metabolism. physiology and biochemistry of lipids important in atherosclerosis, survey of recent work on drugs affecting lipid metabolism, and some attention to epidemiology of atherosclerotic heart disease. Subject and name indexes. ISBN: OCLC Number: Reproduction Notes: Electronic reproduction. [S.l.]: HathiTrust Digital Library, MiAaHDL. Advances in Experimental Medicine and Biology, Volume Pharmacological Control of Lipid Metabolism Diabetes Sep , 22 (9) ; DOI: /diab Share This Article: Copy.
Lipid metabolism, in particular the synthesis of fatty acids (FAs), is an essential cellular process that converts nutrients into metabolic intermediates for membrane biosynthesis, energy storage. Lipid Metabolism focuses on the regulation and metabolism of lipids. This book is composed of 10 chapters that specifically deal with fatty acids, prostaglandins, glycerides, glycerophosphates, cholesterol, isoprenoids, and aromatic compounds. This text starts with an overview of fatty acid metabolism and its controlling Edition: 1. Full text of "The Control Of Lipid Metabolism" See other formats. Objective: Diabetes mellitus is the most common chronic endocrine disease worldwide. Intensive glycemic control plays an important role in decreasing morbidity and mortality rate of the disease. Preclinical studies have shown that biotin has an essential role in regulating blood glucose and serum lipid by:
The Proceedings of the Eight International Symposium on Drugs Affecting Lipid Metabolism (8th D.A.L.M.) is the subject of this volume. Since the first symposium in , each successive meeting has broken new ground in the field of pharmacological control of lipid levels - offering new and stimulating insights and exposing the audience to the state of the art. Abstract. The 7α-hydroxylation of cholesterol is the initial and major rate-limiting step in the conversion of cholesterol into bile acids. The enzyme system cholesterol 7α-hy-droxylase, which catalyzes the introduction of the hydroxyl group in the 7α-position of the cholesterol molecule, is a mixed-function oxidase, cytochrome P dependent and is located in the smooth Author: E. Bosisio. Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases: The Chemical and Pharmacological Basis of their Action focuses on active pharmacological principles that modulate diabetes, associated risk factors, complications and the mechanism of action of widely used anti-diabetic herbal plants—rather than just the. Medicinal Foods as Potential Therapies for Type-2 Diabetes and Associated Diseases: The Chemical and Pharmacological Basis of their Action focuses on active pharmacological principles that modulate diabetes, associated risk factors, complications and the mechanism of action of widely used anti-diabetic herbal plants—rather than just the nutritional composition of certain .